SEVERE APLASTIC ANEMIA (SAA)
Clinical trials for SEVERE APLASTIC ANEMIA (SAA) explained in plain language.
Never miss a new study
Get alerted when new SEVERE APLASTIC ANEMIA (SAA) trials appear
Sign up with your email to follow new studies for SEVERE APLASTIC ANEMIA (SAA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets bone marrow failure
Disease control Not yet recruitingThis study tests an experimental drug called dibotatug (DR-01) in adults with bone marrow failure syndromes, including severe aplastic anemia. The goal is to see if the drug is safe and can improve blood cell counts. Participants receive dibotatug by IV infusion, and researchers …
Matched conditions: SEVERE APLASTIC ANEMIA (SAA)
Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Simpler stem cell collection could ease donor burden in Life-Threatening anemia
Disease control Not yet recruitingThis trial tests whether using only blood stem cells (instead of blood stem cells plus bone marrow) for a half-matched transplant is safe and effective for severe aplastic anemia. 180 patients aged 18-40 will be randomly assigned to one of two graft sources. The main goal is to s…
Matched conditions: SEVERE APLASTIC ANEMIA (SAA)
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New drug cocktail aims to free aplastic anemia patients from transfusions
Disease control Not yet recruitingThis phase 2 trial tests a combination of three drugs—cyclosporine, a thrombopoietin receptor agonist (eltrombopag or hetrombopag), and romiplostim—in 43 adults newly diagnosed with severe aplastic anemia or transfusion-dependent non-severe aplastic anemia. The goal is to see if …
Matched conditions: SEVERE APLASTIC ANEMIA (SAA)
Phase: PHASE2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC